A new report finds high consumer interest in letting AI assistants handle shopping and bills. But when it comes to checkout, trust quickly shifts from the AI to familiar financial institutions like banks and credit card networks.
Wabash National Corporation is permanently closing plants in Minnesota and Indiana, eliminating 270 positions. The move follows a 17.8% year-over-year drop in quarterly sales. Costs for the shutdown are estimated between $15 and $20 million.
A new review of studies finds that people who stop taking GLP-1 obesity medications like semaglutide regain weight quickly, about 1.8 pounds per month. This suggests many may need to stay on the drugs long-term to maintain results.
In a stunning rebuke, Tesla investors voted to reinstate Elon Musk’s $56 billion compensation plan. They also rejected advice from major proxy firms, signaling a major shift in corporate governance.
China’s top market watchdog is cracking down on potential collusion in the booming solar sector. Six leading manufacturers have been summoned and told to submit rectification plans by January 20.
In a major move for cancer drug development, Amgen is buying Dark Blue Therapeutics for a deal worth up to $840 million. The acquisition centers on a novel therapy targeting a hard-to-treat form of leukemia.
NASA is pushing forward with its Artemis program, with the crewed Artemis II mission potentially launching as early as February 2025. This critical test flight around the Moon paves the way for a landing attempt in 2027, though the schedule is tight and faces significant hurdles.
The traditional path of 22 years of school followed by 40 years of work is over. That’s the verdict from leaders at General Catalyst and McKinsey, who say AI is forcing a brutal new reality of non-stop learning just to stay relevant.
Generac is expanding its manufacturing footprint to chase the booming data center market. The company just acquired a new facility in Sussex, Wisconsin, which will create over 100 jobs and help tackle a backlog that recently doubled.
Nvidia CEO Jensen Huang says there is “very high” demand in China for its H200 AI chips. The company is restarting production and finalizing export licenses with the U.S. government.
